• Induced G2/M arrest and apoptosis in cervical, lung, pancreas, and colon cancer in vitro.• Observed antitumor effects in breast cancer cells with p53 depletion in vitro.• Increased the efficacy of chemotherapy in xenograft models of pancreatic cancer in vivo. This evidence concerns the gene TP53 and familial pancreatic carcinoma.